CD2-targeted nanoparticles encapsulating IL-2 induce tolerogenic Tregs and TGF-beta-producing NK cells that stabilize Tregs for long-term therapeutic efficacy in immune-mediated disorders
Related Posts
Shenoy ES, Branch-Elliman W, Wiens J. The Search for the Golden Egg: Applied Large Language Models to Detect Patients With Potential Exposure to Avian Influenza.[...]
Simultaneous or Rapid Sequence Optimization of Medical Therapy for Heart Failure: Time to Keep Score
Shoji S, Fonarow GC, Greene SJ. Simultaneous or Rapid Sequence Optimization of Medical Therapy for Heart Failure: Time to Keep Score. Circ Heart Fail. 2025[...]
Tai JW, Young EH, Shah VD, Reed JP. Ciprofloxacin and Metronidazole As Rare Culprits of Drug-Induced Immune Thrombocytopenia in the Setting of Diverticulitis Treatment. Cureus.[...]